CHCT vs FPI

CHCT exhibits severe valuation misalignment, with a current price of $17.20 trading at a massive premium to its Graham Number ($5.35) and Intrinsic Value ($2.36). While the Piotroski F-Score of 4/9 indicates stable health, the financial fundamentals are undermined by an unsustainable dividend payout ratio of 2356.25% and a trailing P/E of 215.00. Despite a recent 1-year price recovery, the long-term 5-year trend is deeply negative (-52.8%), and the company consistently misses earnings estimates. The high dividend yield is a 'value trap' given that earnings cannot support the current distribution rate.

FPI exhibits significant financial fragility, highlighted by a weak Piotroski F-Score of 3/9 and a severe disconnect between its current price ($11.71) and growth-based intrinsic value ($4.27). While the stock trades near its Graham Number ($12.14), suggesting defensive fair value, this is offset by collapsing earnings growth (-59.80% YoY) and poor liquidity ratios. The sharp increase in Forward P/E (48.79) compared to current P/E (19.20) signals an expected decline in profitability. Despite a low debt-to-equity ratio, the overall deterministic health and growth trajectory are negative.